[Evaluation of a standardized European method for the determination of plasma and erythrocyte cholinesterase].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Colombi.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A retrospective study has been made of mammography data with a view to identifying and analysing a number of epidemiologico-clinical and socio-medical factors involved in the problem of breast cancer. Particular attention was paid to the existence of risk indicators related to malignant cancer of the breast. Routine statistical tests on the data showed that patients with breast cancer differ from other women (healthy or with benign neoplasia, or dysplasia, or suspected malignity, or inflammation) because of the higher frequency of certain features such as the high average age, late menopause, early menarche, longer interval between menarche and first term pregnancy, family history of malignant cancer of all types and of exclusively breast localization. This analysis proved to be in agreement with other data reported in the literature, however, a number of factors considered to be risk indicators were not found: i.e. absence of pregnancy, absence of breast feeding and reduction in the total breast feeding time.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A gas-chromatographic method has been developed for measuring urinary nitrous oxide, halothane and isoflurane concentrations. A volume of head-space gases obtained from biological samples is analyzed by ECD-GC on a steel column (2 mm ID) serially packed with Porapak Q (1.2 m) and MS-5A (0.30 m), operated at 160 degrees C. The detection limit (ranging from 0.03 micrograms/l for halothane to 1 microgram/l for nitrous oxide), between-day precision (CV < 6%) and working linear range (up to 100 micrograms/l for halothane and 2000 micrograms/l for nitrous oxide) were determined. A two-year experience in biological monitoring of occupationally exposed surgical staff with the proposed method is reported and confounding factors are discussed. The method is easy to perform, free from interferences and suitable for use in routine analysis in toxicological laboratories.
A gas chromatographic procedure with dynamic head-space purge and trap preconcentration (HSGC) and FID detection for blood and urinary benzene, toluene, ethylbenzene and xylenes (BTEX) determination at low level exposure is described. Critical steps (sample collection, calibration, HSGC conditions, contamination control) are discussed. The calibration curve is linear in the range 50 ng/l-500 micrograms/l; the calculated detection limit is 50 ng/l for all the considered aromatic hydrocarbons (AH) both in blood and urine; the within-day precision, calculated as variation coefficient (CV) at 400 ng/l and 40 micrograms/l (n = 6) was respectively CV = 13% and CV = 6% for all the studied analytes. The recovery rate was in the range 29-70%, depending on the hydrocarbon and matrix (blood or urine) considered. The procedure was applied to the biological monitoring of 151 workers occupationally or environmentally exposed to BTEX. Occupationally exposed subjects showed blood AH levels of 2-4 order of magnitude higher than environmentally exposed subjects. In white-collar workers exposed to BTEX urban pollution a significant difference in blood and urine levels of AH was observed between nonsmokers and smokers. Nonsmokers showed blood AH median values of respectively benzene = 241 ng/l, toluene = 759 ng/l, ethylbenzene = 140 ng/l, xylenes = 604 ng/l. Significatively higher BTEX blood values were observed in smokers after a median consumption of 5 cigarettes in 5 hours; observed median values were respectively: benzene = 365 ng/l toluene = 1327 ng/l, ethylbenzene = 233 ng/l, xylenes = 794 ng/l.
Explore the source record for details and available documents.
The concept of risk, in relation to human health, is a topic of primary interest for occupational health professionals. A new legislation recently established in Italy (626/94) according to European Community directives in the field of Preventive Medicine, called attention to this topic, and in particular to risk assessment and evaluation. Motivated by this context and by the impression that the concept of risk is frequently misunderstood, the present paper has two aims: the identification of the different meanings of the term "risk" in the new Italian legislation and the critical discussion of some commonly used definitions; and the proposal of a general definition, with the specification of a mathematical expression for quantitative risk estimation. The term risk (and risk estimation, assessment, or evaluation) has mainly referred to three different contexts: hazard identification, exposure assessment, and adverse health effects occurrence. Unfortunately, there are contexts in the legislation in which it is difficult to identify the true meaning of the term. This might cause equivocal interpretations and erroneous applications of the law because hazard evaluation, exposure assessment, and adverse health effects identification are completely different topics that require integrated but distinct approaches to risk management. As far as a quantitative definition of risk is of concern, we suggest an algorithm which connects the three basic risk elements (hazard, exposure, adverse health effects) by means of their probabilities of occurrence: the probability of being exposed (to a definite dose) given that a specific hazard is present (Pr(e[symbol: see text]p)), and the probability of occurrence of an adverse health effect as a consequence of that exposure (Pr(d[symbol: see text]e)). Using these quantitative components, risk can be defined as a sequence of measurable events that starts with hazard identification and terminates with disease occurrence; therefore, the following formal definition of risk is proposed: the probability of occurrence, in a given period of time, of an adverse health effect as a consequence of the existence of an hazard. In formula: R(d[symbol: see text]p) = Pr(e[symbol: see text]p) x Pr(d[symbol: see text]e). While Pr(e[symbol: see text]p) (exposure given hazard) must be evaluated in the situation under study, two alternatives exist for the estimation of the occurrence of adverse health effects (Pr(d[symbol: see text]e)): a "direct" estimation of the damage (Pr(d[symbol: see text]e) through formal epidemiologic studies conducted in the situation under observation; and an "indirect" estimation of Pr(d[symbol: see text]e) using information taken from the scientific literature (epidemiologic evaluations, dose-response relationships, extrapolations, ...). Both conditions are presented along with their respective advantages, disadvantages, and uncertainties. The usefulness of the proposed algorithm is discussed with respect to commonly used applications of risk assessment in occupational medicine; the relevance of time for risk estimation (both in the term of duration of observation, duration of exposure, and latency of effect) is briefly explained; and how the proposed algorithm takes into account (in terms of prevention and public health) both the etiologic relevance of the exposure and the consequences of exposure removal is highlighted. As a last comment, it is suggested that the diffuse application of good work practices (technical, behavioral, organizational, ...), or the exhaustive use of check lists, can be relevant in terms of improvement of prevention efficacy, but does not represent any quantitative procedure of risk assessment which, in any circumstance, must be considered the elective approach to adverse health effect prevention.